VyCAP
PrivateLast Round
Seed
Feb 19, 2016
Company Overview
VyCAP is a medical technology company that develops and manufactures innovative solutions for the isolation, identification, and analysis of cells from biological fluid samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VyCAP Comparables
Compare VyCAP with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell Microsystems | 80% | |
| CelLBxHealth plc | 77% | |
| RareCyte | 77% | |
VyCAP Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 19, 2016 |
VyCAP Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| High Tech Funds | Seed |
| East Netherlands Development Agency (Oost NL) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2016
Seed round with participation from Oost NL and High Tech Funds.
VyCAP Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VyCAP's valuation, stock price, and market status.